FTSE All-Share
5.211,88
PKT
-29,02
PKT
-0,55
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.12.20 | Vodafone Group buy | UBS AG | |
| 14.12.20 | AstraZeneca buy | Kepler Cheuvreux | |
| 14.12.20 | GSK Neutral | UBS AG | |
| 14.12.20 | AstraZeneca Neutral | UBS AG | |
| 14.12.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 14.12.20 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 14.12.20 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.12.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 14.12.20 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 11.12.20 | Lloyds Banking Group Sell | Goldman Sachs Group Inc. | |
| 11.12.20 | HSBC buy | Goldman Sachs Group Inc. | |
| 11.12.20 | BP buy | Kepler Cheuvreux | |
| 11.12.20 | BP buy | Kepler Cheuvreux | |
| 11.12.20 | Vodafone Group buy | Jefferies & Company Inc. | |
| 11.12.20 | GSK buy | Jefferies & Company Inc. | |
| 10.12.20 | BAT Outperform | Credit Suisse Group | |
| 10.12.20 | Rio Tinto Equal-Weight | Morgan Stanley | |
| 10.12.20 | Rio Tinto Neutral | Goldman Sachs Group Inc. | |
| 09.12.20 | National Grid overweight | Barclays Capital | |
| 09.12.20 | Vodafone Group buy | Merrill Lynch & Co., Inc. | |
| 09.12.20 | AstraZeneca Neutral | UBS AG | |
| 09.12.20 | BP Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.12.20 | Shell (ex Royal Dutch Shell) buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.12.20 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 08.12.20 | BAT Hold | Jefferies & Company Inc. | |
| 08.12.20 | GSK Neutral | JP Morgan Chase & Co. | |
| 07.12.20 | Vodafone Group buy | Goldman Sachs Group Inc. | |
| 07.12.20 | AstraZeneca overweight | Morgan Stanley | |
| 07.12.20 | Vodafone Group buy | Kepler Cheuvreux | |
| 04.12.20 | Lloyds Banking Group Sell | Goldman Sachs Group Inc. | |
| 04.12.20 | Barclays Neutral | Goldman Sachs Group Inc. | |
| 04.12.20 | HSBC buy | Goldman Sachs Group Inc. | |
| 04.12.20 | National Grid Outperform | Credit Suisse Group | |
| 04.12.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 03.12.20 | Shell (ex Royal Dutch Shell) Outperform | Bernstein Research | |
| 03.12.20 | GSK Neutral | UBS AG | |
| 03.12.20 | BAT overweight | JP Morgan Chase & Co. | |
| 03.12.20 | Unilever Neutral | JP Morgan Chase & Co. | |
| 03.12.20 | Unilever Outperform | Credit Suisse Group | |
| 03.12.20 | Lloyds Banking Group Outperform | Credit Suisse Group |